Fujifilm Irvine Scientific completes construction of Netherlands production facility, enters validation stagenews2021-09-30T13:58:06+00:00September 30th, 2021|Fierce Pharma|
Merck CEO downplays PAH drug’s antitrust threat as it wades deeper into cardiovascular disease with $11.5B Acceleron buynews2021-09-30T13:46:40+00:00September 30th, 2021|Fierce Pharma|
Takeda, JCR ink deal to commercialize Hunter syndrome drug in key marketsnews2021-09-30T13:34:12+00:00September 30th, 2021|Fierce Pharma|
MannKind raises $102M in sale-leaseback of manufacturing plant to fund operationsnews2021-09-30T12:57:30+00:00September 30th, 2021|Fierce Pharma|
Regeneron’s COVID-19 antibody cocktail pads case for saving lives in hospitalized patients as FDA decision nearsnews2021-09-30T09:09:21+00:00September 30th, 2021|Fierce Pharma|
Fierce Pharma awards best-in-class marketing campaigns in 3rd annual contest—and first live eventnews2021-09-30T03:37:04+00:00September 30th, 2021|Fierce Pharma|
Pharma’s ‘painful’ social media start morphs into refined content strategies across even hipster channels: expertsnews2021-09-29T21:59:02+00:00September 29th, 2021|Fierce Pharma|
Mirum gets iBAT inhibitor Livmarli across the FDA finish line for rare pediatric liver conditionnews2021-09-29T19:30:00+00:00September 29th, 2021|Fierce Pharma|
Despite rough start, Biogen’s Aduhelm should find footing, analysts say. But don’t expect much in 2021news2021-09-29T17:54:42+00:00September 29th, 2021|Fierce Pharma|
Samsung Biologics sees more than 10x growth in value of CMO deal with Rochenews2021-09-29T16:36:06+00:00September 29th, 2021|Fierce Pharma|
